3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Thromboembolism
1
Sarcoma
1
Pulmonary Embolism
1
Multiple Myeloma
1
Lymphoma
1
Leukemia
1
Hematologic Neoplasms
1
Interventions
Rivaroxaban
3
apixaban
2
Heparin, Low-Molecular-Weight
2
Fondaparinux
2
Enoxaparin
2
Dalteparin
2
enoxaparin sodium
1
edoxaban
1
Warfarin
1
Tinzaparin
1
Nadroparin
1
Long-Term Synaptic Depression
1
Hematologic Tests
1
Educational Status
1
Dabigatran
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Venous Thromboembolism
×
enoxaparin sodium
×
Clear all
NCT07270263
2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA
Recruiting
100 enrolled